Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Jan 2000

Bar J K, Harłozińska A, Popiela A, Noga L

Abstract excerpt

p53 alterations are considered as one of the most important factors responsible for drug resistance in ovarian carcinomas, although the relationship between p53 gene status and response to cisplatin-based chemotherapy in ovarian cancer patients remains unclear. The aim of the study was to evaluate the relationship between p53 protein accumulation, p53 gene mutation and response to cisplatin-based chemotherapy in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Ascites

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma

Share to Carcinoma, Endometrioid

Share to Cisplatin

Share to Cystadenocarcinoma, Serous

Share to Genes, p53

Share to Polymorphism, Single-Stranded Conformational

Source

Identifiers

PMID: 11125280
DOI: 10.1159/000050601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.PMID 11125280Read ↗

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.Semantic proximity Read ↗

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Semantic proximity Read ↗

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.Semantic proximity Read ↗

The role of p53 as a surrogate marker for chemotherapeutical responsiveness in ovarian cancer.Semantic proximity Read ↗

p53 gene status and chemosensitivity in ovarian cancer.Semantic proximity Read ↗

TP53 and ovarian cancer.Semantic proximity Read ↗

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.Semantic proximity Read ↗

Critical evaluation of p53 as a prognostic marker in ovarian cancerSemantic proximity Read ↗

Determination of Both TP53 Mutation Status and the Amount of p53 Protein has Limited Diagnostic Importance for Patients with Ovarian Cancer.Semantic proximity Read ↗

p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance.Semantic proximity Read ↗

Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer?Semantic proximity Read ↗

Alteration of p53 gene in ovarian carcinoma: clinicopathological correlation and prognostic significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.